NextCure NXTC
NASDAQ NXTC
$6.40 +0.17 (+2.73%)
At close: Nov 13, 2026 · 4:00 PM EST

NextCure (NXTC) Price to Sales (2019 - 2020)

Updated

NextCure's (NXTC) Price to Sales came in at 13.43 for Q4 2020, down 90.4% from 139.29 a year earlier but up 35.0% from the prior quarter.

Analysis

NextCure (NXTC) Price to Sales (2019 - 2020) Analysis & Trends

Since Q4 2019, NextCure has reported Price to Sales for 5 quarters.

  • In prior years, NextCure's Price to Sales was 139.29 in FY2019.
  • Quarterly Price to Sales has run from a low of 9.94 in Q3 2020 to a high of 139.29 in Q4 2019 over five years.
  • According to Business Quant data, Price to Sales for the three prior quarters was 9.94 (Q3 2020), 22.72 (Q2 2020) and 37.27 (Q1 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 NextCure 29.30 Mn -71.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 13.43
Sep 30, 2020 9.94
Jun 30, 2020 22.72
Mar 31, 2020 37.27
Dec 31, 2019 139.29
API Access

NextCure Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=NXTC&period=max&api_key=YOUR_API_KEY